| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0026-0495(80)90213-9 |
| P698 | PubMed publication ID | 7001174 |
| P2093 | author name string | Ensinck JW | |
| Walter RM Jr | |||
| Gold EM | |||
| Michas CA | |||
| P433 | issue | 11 | |
| P921 | main subject | glucagon | Q28163629 |
| obesity | Q12174 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 1037-1040 | |
| P577 | publication date | 1980-10-01 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects. | |
| P478 | volume | 29 |
| Q68750216 | Enzyme activity patterns of phosphoenolpyruvate carboxykinase, pyruvate kinase, glucose-6-phosphate-dehydrogenase and malic enzyme in human liver |
| Q34182136 | Epinephrine is not critical to prevention of hypoglycemia during exercise in humans |
| Q34602608 | Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man |
| Q34529475 | Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects |
| Q34519321 | Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion |
| Q51646267 | Hyperinsulinemia of obesity is due to decreased clearance of insulin |
| Q39661406 | Insulin resistance and amino acid metabolism in obesity |
| Q33821886 | Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion |
| Q34551426 | Splanchnic insulin metabolism in obesity. Influence of body fat distribution |
| Q100955696 | The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview |
| Q71622783 | The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP) |
Search more.